ANNE MAYNARD: Open Payments
NPI 1336476985 · GLEN ELLYN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,992 in 100 payments from 26 companies in 2025. Trend: 2023 $1,794 · 2024 $1,894 · 2025 $1,992
Food & beverage: $1,992
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 34 | $500 |
| Novo Nordisk Inc | 8 | $244 |
| Lilly USA, LLC | 12 | $199 |
| Amgen Inc. | 6 | $194 |
| Radius Health, Inc. | 5 | $92 |
| Sequel Med Tech, LLC | 4 | $89 |
| Tandem Diabetes Care, Inc. | 4 | $78 |
| Insulet Corporation | 3 | $77 |
| Ascendis Pharma Endocrinology Inc | 3 | $49 |
| BETA BIONICS, INC. | 2 | $44 |
Products named: FREESTYLE LIBRE 3, EVENITY, Ozempic, MOUNJARO, JARDIANCE, Tymlos, TWIIST, Rybelsus.
Industry payments across IL — which companies pay providers there.
